The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCURAY INC | COM | 004397105 | 11,593 | 1,535,475 | SH | SOLE | 1,535,475 | 0 | 0 | ||
| ACHAOGEN INC | COM | 004449104 | 9,578 | 733,953 | SH | SOLE | 733,953 | 0 | 0 | ||
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 257 | 1,390 | SH | SOLE | 1,390 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 57,202 | 6,875,274 | SH | SOLE | 6,875,274 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | COM | 04269X105 | 56,090 | 11,858,294 | SH | SOLE | 11,858,294 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | NOTE 3.000% 6/0 | 04269XAA3 | 1,869 | 2,000,000 | PRN | SOLE | 2,000,000 | 0 | 0 | ||
| ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 18,180 | 258,305 | SH | SOLE | 258,305 | 0 | 0 | ||
| ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 7,069 | 264,266 | SH | SOLE | 264,266 | 0 | 0 | ||
| AVALANCHE BIOTECHNOLOGIES IN | COM | 05337G107 | 37,750 | 699,070 | SH | SOLE | 699,070 | 0 | 0 | ||
| BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 17,269 | 860,809 | SH | SOLE | 860,809 | 0 | 0 | ||
| BIOGEN IDEC INC | COM | 09062X103 | 14,635 | 43,113 | SH | SOLE | 43,113 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 9,376 | 102,227 | SH | SOLE | 102,227 | 0 | 0 | ||
| CASTLIGHT HEALTH INC | CL B | 14862Q100 | 14,593 | 1,247,268 | SH | SOLE | 1,247,268 | 0 | 0 | ||
| CELGENE CORP | COM | 151020104 | 38,295 | 342,349 | SH | SOLE | 342,349 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM | 15117B103 | 476 | 26,100 | SH | SOLE | 26,100 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 46,588 | 1,157,184 | SH | SOLE | 1,157,184 | 0 | 0 | ||
| CIVITAS SOLUTIONS INC | COM | 17887R102 | 14,978 | 879,485 | SH | SOLE | 879,485 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 40,411 | 721,632 | SH | SOLE | 721,632 | 0 | 0 | ||
| CONNECTURE INC | COM | 20786J106 | 8,496 | 943,000 | SH | SOLE | 943,000 | 0 | 0 | ||
| EHEALTH INC | COM | 28238P109 | 6,602 | 264,942 | SH | SOLE | 264,942 | 0 | 0 | ||
| ELEVEN BIOTHERAPEUTICS INC | COM | 286221106 | 2,851 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
| FLEXION THERAPEUTICS INC | COM | 33938J106 | 6,363 | 315,144 | SH | SOLE | 315,144 | 0 | 0 | ||
| FLUIDIGM CORP DEL | COM | 34385P108 | 20,590 | 610,442 | SH | SOLE | 610,442 | 0 | 0 | ||
| FORWARD PHARMA A/S | SPONSORED ADR | 34986J105 | 526 | 25,235 | SH | SOLE | 25,235 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 34,746 | 368,615 | SH | SOLE | 368,615 | 0 | 0 | ||
| GLOBUS MED INC | CL A | 379577208 | 14,541 | 611,731 | SH | SOLE | 611,731 | 0 | 0 | ||
| HEALTH NET INC | COM | 42222G108 | 16,543 | 309,045 | SH | SOLE | 309,045 | 0 | 0 | ||
| HEALTHWAYS INC | COM | 422245100 | 21,242 | 1,068,489 | SH | SOLE | 1,068,489 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 15,661 | 1,012,371 | SH | SOLE | 1,012,371 | 0 | 0 | ||
| INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 17,488 | 990,810 | SH | SOLE | 990,810 | 0 | 0 | ||
| ISHARES | US HLTHCR PR ETF | 464288828 | 296 | 2,500 | SH | SOLE | 2,500 | 0 | 0 | ||
| ISHARES TR | NASDQ BIOTEC ETF | 464287556 | 303 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 1,618 | 137,681 | SH | SOLE | 137,681 | 0 | 0 | ||
| MARKET VECTORS ETF TR | PHARMACEUTICAL | 57060U217 | 418 | 6,500 | SH | SOLE | 6,500 | 0 | 0 | ||
| MCKESSON CORP | COM | 58155Q103 | 18,168 | 87,523 | SH | SOLE | 87,523 | 0 | 0 | ||
| MODEL N INC | COM | 607525102 | 15,523 | 1,461,678 | SH | SOLE | 1,461,678 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 17,643 | 1,266,538 | SH | SOLE | 1,266,538 | 0 | 0 | ||
| NEVRO CORP | COM | 64157F103 | 9,059 | 234,254 | SH | SOLE | 234,254 | 0 | 0 | ||
| NUVASIVE INC | COM | 670704105 | 16,915 | 358,679 | SH | SOLE | 358,679 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 14,587 | 1,070,995 | SH | SOLE | 1,070,995 | 0 | 0 | ||
| PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 1,866 | 237,977 | SH | SOLE | 237,977 | 0 | 0 | ||
| POWERSHARES QQQ TRUST | UNIT SER 1 | 73935A104 | 355 | 3,434 | SH | SOLE | 3,434 | 0 | 0 | ||
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 15,729 | 751,171 | SH | SOLE | 751,171 | 0 | 0 | ||
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 17,766 | 93,865 | SH | SOLE | 93,865 | 0 | 0 | ||
| RECEPTOS INC | COM | 756207106 | 38,313 | 312,736 | SH | SOLE | 312,736 | 0 | 0 | ||
| RITE AID CORP | COM | 767754104 | 45,411 | 6,038,734 | SH | SOLE | 6,038,734 | 0 | 0 | ||
| SEATTLE GENETICS INC | COM | 812578102 | 31,615 | 983,966 | SH | SOLE | 983,966 | 0 | 0 | ||
| SUNESIS PHARMACEUTICALS INC | COM NEW | 867328601 | 64 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| TOKAI PHARMACEUTICALS INC | COM | 88907J107 | 3,171 | 215,139 | SH | SOLE | 215,139 | 0 | 0 | ||
| TRIVASCULAR TECHNOLOGIES INC | COM | 89685A102 | 22,067 | 1,755,568 | SH | SOLE | 1,755,568 | 0 | 0 | ||
| UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 15,050 | 135,270 | SH | SOLE | 135,270 | 0 | 0 | ||
| VALEANT PHARMACEUTICALS INTL | COM | 91911K102 | 48,439 | 338,477 | SH | SOLE | 338,477 | 0 | 0 | ||
| WELLCARE HEALTH PLANS INC | COM | 94946T106 | 401 | 4,887 | SH | SOLE | 4,887 | 0 | 0 | ||
| ZS PHARMA INC | COM | 98979G105 | 21,812 | 524,702 | SH | SOLE | 524,702 | 0 | 0 | ||